Showing 2221-2230 of 4456 results for "".
Your Destination for the Latest Developments in #Dermatology in Print and Online
https://practicaldermatology.com/topics/practice-management/your-destination-for-the-latest-developments-in-dermatology-in-print-and-online/20921/Your Destination for the Latest Developments in #Dermatology in Print and Online
https://practicaldermatology.com/topics/general-topics/your-destination-for-the-latest-developments-in-dermatology-in-print-and-online/20983/A Practical Approach: Field Treatment of AKs with PDT
https://practicaldermatology.com/issues/supplements/a-practical-approach-field-treatment-of-aks-with-pdt/20431/Why it's essential to treat visible and invisible actinic keratosis lesions and how PDT fits into the treatment armamentarium.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-5/23092/New In My Practice: Cosmeceutical
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-in-my-practice-cosmeceutical-1/23986/Merz Aesthetics’ Neocutis Neo Restore Post Treatment Nourishing Sheet MaskUpdate on Injectable Aesthetics
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/update-on-injectable-aesthetics/23467/Taking a More Holistic View of the Pathogenesis of Acne
https://practicaldermatology.com/topics/acne-rosacea/taking-more-holistic-view-pathogenesis-acne/26539/Taking a More Holistic View of the Pathogenesis of AcneSpecial Report: Dermatology Industry Responds to Inequities in Care
https://practicaldermatology.com/topics/skin-of-color/special-report-dermatology-industry-responds-to-inequities-in-care/23765/A Case of Pityriasis Lichenoides; Low-Tech/High-Yield Tech Solutions
https://practicaldermatology.com/topics/general-topics/a-case-of-pityriasis-lichenoides-low-techhigh-yield-tech-solutions/20537/Case Report: A 61-year-old man with Pityriasis LichenoidesA Closer Look at Cibinqo for AD Management
https://practicaldermatology.com/topics/atopic-dermatitis/a-closer-look-at-cibinqo-for-ad-management/23664/Oral JAK inhibitors offer rapid onset of efficacy and some flexibility in the management of moderate to severe eczema.